HIKALNSEHikal Limited· PharmaceuticalsMediumNeutral
Announced Wed, 27 May · 16:10 IST

Appointment of SMP

Management Changes View source PDF

HIKAL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-12.9%1-day move
₹220.99
prior close
₹209.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-2.2-1.9-2.0-2.9-12.9-13.2-14.8-13.3-14.4-17.8-7.0-3.1
Up moveDown movePending
AI summary

Hikal Limited disclosed two items under SEBI Regulation 30. First, the company appointed Mr. Ravi Khadabadi as President - Crop Protection & Specialty Chemicals, effective May 27, 2026. He holds a master's degree in chemistry and Polymers from Mumbai and University of Massachusetts Lowell, USA, bringing extensive experience in Pharma and Specialty Chemicals industries. Second, the company provided an update on previously disclosed employee irregularities from December 2025 related to timing of revenue recognition. The external review concluded the irregularities were limited to preponegement of genuine sales, with no financial impact on current or previous periods. The employees involved have been relieved from services.

Likely market impact

The appointment strengthens the company's leadership in its Crop Protection & Specialty Chemicals division. The resolved fraud matter with no financial impact and corrective action taken on employees is a positive governance development.